Diprosone and Colitis - a phase IV clinical study of FDA data

Summary:

Colitis is reported as a side effect among people who take Diprosone (betamethasone dipropionate), especially for people who are male, 40-49 old, also take Morphine, and have Lung neoplasm malignant.

The phase IV clinical study analyzes which people have Colitis when taking Diprosone. It is created by eHealthMe based on reports of 2,034 people who have side effects when taking Diprosone from the FDA, and is updated regularly.

What is Diprosone?

Diprosone has active ingredients of betamethasone dipropionate. eHealthMe is studying from 2,045 Diprosone users. Check the latest studies of Diprosone.

What is Colitis?

Colitis (inflammation of colon) is found to be associated with 1,595 drugs and 1,524 conditions by eHealthMe. Check the latest studies of Colitis.

On Jul, 29, 2026

2,034 people reported to have side effects when taking Diprosone.
Among them, 14 people (0.69%) have Colitis.

Among these 14 people:

What is the gender of people who have Colitis when taking Diprosone? *

female: 21.43 %
male: 78.57 %

What is the age of people who have Colitis when taking Diprosone? *

What are other drugs people take besides Diprosone? *

What are other side effects people have besides Colitis? *

Amyotrophy (muscular wasting or atrophy): 8 people, 57.14%
Thyroid Diseases: 8 people, 57.14%
Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 8 people, 57.14%
Pemphigoid (tense blisters on the skin): 8 people, 57.14%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 8 people, 57.14%
Systemic Inflammatory Response Syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection): 8 people, 57.14%
Cardio-Respiratory Arrest (sudden dysfunction of heart and lungs): 8 people, 57.14%
Umbilical Hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button): 8 people, 57.14%
Urinary Retention (the inability to completely or partially empty the bladder): 8 people, 57.14%
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream): 8 people, 57.14%

What are the existing conditions these people have? *

Itching: 8 people, 57.14%
Lung Neoplasm Malignant (cancer tumour of lung): 8 people, 57.14%
Thyroid Cancer: 2 people, 14.29%
Nausea (feeling of having an urge to vomit): 2 people, 14.29%
Weakness: 1 person, 7.14%
Hair Disorder: 1 person, 7.14%
Fluid Imbalance (imbalance of fluid in body in intake and fluid lost): 1 person, 7.14%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 7.14%
Fatigue (feeling of tiredness): 1 person, 7.14%
Depression: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Diprosone and have Colitis?

- Check whether Colitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Diprosone:

Diprosone (2,045 reports)

Colitis treatments and more:

Colitis (53,790 reports)

Browse all side effects of Diprosone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Colitis:

Colitis (1,595 drugs)

Browse all the conditions that are associated with Colitis:

Colitis (1,524 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on betamethasone dipropionate (the active ingredients of Diprosone) and Diprosone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.